Table 1

Patient data before and following the first dose of T-VEC

Patient data for characteristics before the first dose of T-VECPatient data for events following the first dose of T-VEC
DemographicsUse of T-VEC (dosage, duration)
Clinical characteristics and comorbiditiesUse of other anti-melanoma treatments
Tumor characteristicsAdverse events
Laboratory parametersBest overall response

  • T-VEC, talimogene laherparepvec.